The New England journal of medicine, 2017-08, Vol.377 (8), p.745-755
- Bress, Adam P
- Bellows, Brandon K
- King, Jordan B
- Hess, Rachel
- Beddhu, Srinivasan
- Zhang, Zugui
- Berlowitz, Dan R
- Conroy, Molly B
- Fine, Larry
- Oparil, Suzanne
- Morisky, Donald E
- Kazis, Lewis E
- Ruiz-Negrón, Natalia
- Powell, Jamie
- Tamariz, Leonardo
- Whittle, Jeff
- Wright, Jackson T
- Supiano, Mark A
- Cheung, Alfred K
- Weintraub, William S
- Moran, Andrew E
2017
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Bress, Adam P
- Bellows, Brandon K
- King, Jordan B
- Hess, Rachel
- Beddhu, Srinivasan
- Zhang, Zugui
- Berlowitz, Dan R
- Conroy, Molly B
- Fine, Larry
- Oparil, Suzanne
- Morisky, Donald E
- Kazis, Lewis E
- Ruiz-Negrón, Natalia
- Powell, Jamie
- Tamariz, Leonardo
- Whittle, Jeff
- Wright, Jackson T
- Supiano, Mark A
- Cheung, Alfred K
- Weintraub, William S
- Moran, Andrew E
- Titel
- Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control
- Ist Teil von
- The New England journal of medicine, 2017-08, Vol.377 (8), p.745-755
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2017
- Quelle
- Free E-Journal (出版社公開部分のみ）
- Beschreibungen/Notizen
- In a cost-effectiveness analysis, intensive blood-pressure control rather than standard treatment (target, <120 mm Hg vs. <140 mm Hg) was associated with an incremental cost-effectiveness ratio of about $47,000 per quality-adjusted life-year gained.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793eISSN: 1533-4406DOI: 10.1056/NEJMsa1616035Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5708850
- Format
- –
- Schlagworte
- Acute coronary syndromes, Adult, Antihypertensive Agents - administration & dosage, Antihypertensive Agents - economics, Blood pressure, Cardiovascular disease, Cardiovascular diseases, Cardiovascular Diseases - economics, Cardiovascular Diseases - mortality, Cardiovascular Diseases - prevention & control, Cardiovascular system, Cost analysis, Cost of Illness, Cost-Benefit Analysis, Estimates, Health care, Health Care Costs, Health care expenditures, Health care policy, Health risks, Heart attacks, Heart failure, Humans, Hypertension, Hypertension - drug therapy, Hypertension - economics, Medicine, Models, Economic, Public health, Quality-Adjusted Life Years